TY - JOUR AU - Siegel, R. L. AU - Miller, K. D. AU - Jemal, A. PY - 2018 DA - 2018// TI - Cancer statistics, 2018 JO - CA Cancer J Clin VL - 68 UR - https://doi.org/10.3322/caac.21442 DO - 10.3322/caac.21442 ID - Siegel2018 ER - TY - JOUR AU - Luke, J. J. AU - Flaherty, K. T. AU - Ribas, A. AU - Long, G. V. PY - 2017 DA - 2017// TI - Targeted agents and immunotherapies: optimizing outcomes in melanoma JO - Nat Rev Clin Oncol VL - 14 UR - https://doi.org/10.1038/nrclinonc.2017.43 DO - 10.1038/nrclinonc.2017.43 ID - Luke2017 ER - TY - JOUR AU - Meng, X. AU - Liu, Y. AU - Zhang, J. AU - Teng, F. AU - Xing, L. AU - Yu, J. PY - 2017 DA - 2017// TI - PD-1/PD-L1 checkpoint blockades in non-small cell lung cancer: new development and challenges JO - Cancer Lett VL - 405 UR - https://doi.org/10.1016/j.canlet.2017.06.033 DO - 10.1016/j.canlet.2017.06.033 ID - Meng2017 ER - TY - JOUR AU - Wainberg, Z. A. AU - Hochster, H. S. AU - George, B. AU - Gutierrez, M. AU - Johns, M. E. AU - Chiorean, E. G. PY - 2017 DA - 2017// TI - Phase I study of nivolumab (nivo) + nab -paclitaxel ( nab -P) ± gemcitabine (Gem) in solid tumors: Interim results from the pancreatic cancer (PC) cohorts JO - J Clin Oncol VL - 35 UR - https://doi.org/10.1200/JCO.2017.35.4_suppl.412 DO - 10.1200/JCO.2017.35.4_suppl.412 ID - Wainberg2017 ER - TY - JOUR AU - Le, D. T. AU - Durham, J. N. AU - Smith, K. N. AU - Wang, H. AU - Bartlett, B. R. AU - Aulakh, L. K. PY - 2017 DA - 2017// TI - Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade JO - Science. VL - 357 UR - https://doi.org/10.1126/science.aan6733 DO - 10.1126/science.aan6733 ID - Le2017 ER - TY - JOUR AU - Masugi, Y. AU - Nishihara, R. AU - Hamada, T. AU - Song, M. AU - Silva, A. AU - Kosumi, K. PY - 2017 DA - 2017// TI - Tumor PDCD1LG2 (PD-L2) expression and the lymphocytic reaction to colorectal Cancer JO - Cancer Immunol Res VL - 5 UR - https://doi.org/10.1158/2326-6066.CIR-17-0122 DO - 10.1158/2326-6066.CIR-17-0122 ID - Masugi2017 ER - TY - JOUR AU - Remmele, W. AU - Stegner, H. E. PY - 1987 DA - 1987// TI - Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue JO - Pathologe VL - 8 ID - Remmele1987 ER - TY - JOUR AU - Subramanian, A. AU - Tamayo, P. AU - Mootha, V. K. AU - Mukherjee, S. AU - Ebert, B. L. AU - Gillette, M. A. PY - 2005 DA - 2005// TI - Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles JO - Proc Natl Acad Sci U S A VL - 102 UR - https://doi.org/10.1073/pnas.0506580102 DO - 10.1073/pnas.0506580102 ID - Subramanian2005 ER - TY - JOUR AU - Zhu, R. AU - Kosorok, M. R. PY - 2012 DA - 2012// TI - Recursively imputed survival trees JO - J Am Stat Assoc VL - 107 UR - https://doi.org/10.1080/01621459.2011.637468 DO - 10.1080/01621459.2011.637468 ID - Zhu2012 ER - TY - JOUR AU - Yang, H. I. AU - Yuen, M. F. AU - Chan, H. L. AU - Han, K. H. AU - Chen, P. J. AU - Kim, D. Y. PY - 2011 DA - 2011// TI - Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score JO - Lancet Oncol VL - 12 UR - https://doi.org/10.1016/S1470-2045(11)70077-8 DO - 10.1016/S1470-2045(11)70077-8 ID - Yang2011 ER - TY - JOUR AU - Zhou, M. AU - Zhao, H. AU - Wang, Z. AU - Cheng, L. AU - Yang, L. AU - Shi, H. PY - 2015 DA - 2015// TI - Identification and validation of potential prognostic lncRNA biomarkers for predicting survival in patients with multiple myeloma JO - J Exp Clin Cancer Res VL - 34 UR - https://doi.org/10.1186/s13046-015-0219-5 DO - 10.1186/s13046-015-0219-5 ID - Zhou2015 ER - TY - JOUR AU - Moons, K. G. AU - Altman, D. G. AU - Reitsma, J. B. AU - Ioannidis, J. P. AU - Macaskill, P. AU - Steyerberg, E. W. PY - 2015 DA - 2015// TI - Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): explanation and elaboration JO - Ann Intern Med VL - 162 UR - https://doi.org/10.7326/M14-0698 DO - 10.7326/M14-0698 ID - Moons2015 ER - TY - JOUR AU - Hiraoka, N. AU - Onozato, K. AU - Kosuge, T. AU - Hirohashi, S. PY - 2006 DA - 2006// TI - Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions JO - Clin Cancer Res VL - 12 UR - https://doi.org/10.1158/1078-0432.CCR-06-0369 DO - 10.1158/1078-0432.CCR-06-0369 ID - Hiraoka2006 ER - TY - JOUR AU - Imai, D. AU - Yoshizumi, T. AU - Okano, S. AU - Uchiyama, H. AU - Ikegami, T. AU - Harimoto, N. PY - 2017 DA - 2017// TI - The prognostic impact of programmed cell death ligand 1 and human leukocyte antigen class I in pancreatic cancer JO - Cancer Med VL - 6 UR - https://doi.org/10.1002/cam4.1087 DO - 10.1002/cam4.1087 ID - Imai2017 ER - TY - JOUR AU - Wang, L. AU - Ma, Q. AU - Chen, X. AU - Guo, K. AU - Li, J. AU - Zhang, M. PY - 2010 DA - 2010// TI - Clinical significance of B7-H1 and B7-1 expressions in pancreatic carcinoma JO - World J Surg VL - 34 UR - https://doi.org/10.1007/s00268-010-0448-x DO - 10.1007/s00268-010-0448-x ID - Wang2010 ER - TY - JOUR AU - Wang, Y. AU - Lin, J. AU - Cui, J. AU - Han, T. AU - Jiao, F. AU - Meng, Z. PY - 2017 DA - 2017// TI - Prognostic value and clinicopathological features of PD-1/PD-L1 expression with mismatch repair status and desmoplastic stroma in Chinese patients with pancreatic cancer JO - Oncotarget VL - 8 ID - Wang2017 ER - TY - JOUR AU - Brahmer, J. R. AU - Tykodi, S. S. AU - Chow, L. Q. AU - Hwu, W. J. AU - Topalian, S. L. AU - Hwu, P. PY - 2012 DA - 2012// TI - Safety and activity of anti-PD-L1 antibody in patients with advanced cancer JO - N Engl J Med VL - 366 UR - https://doi.org/10.1056/NEJMoa1200694 DO - 10.1056/NEJMoa1200694 ID - Brahmer2012 ER - TY - JOUR AU - Yearley, J. H. AU - Gibson, C. AU - Yu, N. AU - Moon, C. AU - Murphy, E. AU - Juco, J. PY - 2017 DA - 2017// TI - PD-L2 expression in human tumors: relevance to anti-PD-1 therapy in Cancer JO - Clin Cancer Res VL - 23 UR - https://doi.org/10.1158/1078-0432.CCR-16-1761 DO - 10.1158/1078-0432.CCR-16-1761 ID - Yearley2017 ER - TY - JOUR AU - Wang, H. AU - Yao, H. AU - Li, C. AU - Liang, L. AU - Zhang, Y. AU - Shi, H. PY - 2017 DA - 2017// TI - PD-L2 expression in colorectal cancer: independent prognostic effect and targetability by deglycosylation JO - Oncoimmunology VL - 6 UR - https://doi.org/10.1080/2162402X.2017.1327494 DO - 10.1080/2162402X.2017.1327494 ID - Wang2017 ER - TY - JOUR AU - Jung, H. I. AU - Jeong, D. AU - Ji, S. AU - Ahn, T. S. AU - Bae, S. H. AU - Chin, S. PY - 2017 DA - 2017// TI - Overexpression of PD-L1 and PD-L2 is associated with poor prognosis in patients with hepatocellular carcinoma JO - Cancer Res Treat VL - 49 UR - https://doi.org/10.4143/crt.2016.066 DO - 10.4143/crt.2016.066 ID - Jung2017 ER - TY - JOUR AU - Baptista, M. Z. AU - Sarian, L. O. AU - Derchain, S. F. AU - Pinto, G. A. AU - Vassallo, J. PY - 2016 DA - 2016// TI - Prognostic significance of PD-L1 and PD-L2 in breast cancer JO - Hum Pathol VL - 47 UR - https://doi.org/10.1016/j.humpath.2015.09.006 DO - 10.1016/j.humpath.2015.09.006 ID - Baptista2016 ER - TY - JOUR AU - Fontana, A. AU - Copetti, M. AU - Gangi, I. M. AU - Mazza, T. AU - Tavano, F. AU - Gioffreda, D. PY - 2016 DA - 2016// TI - Development of a metabolites risk score for one-year mortality risk prediction in pancreatic adenocarcinoma patients JO - Oncotarget VL - 7 UR - https://doi.org/10.18632/oncotarget.7108 DO - 10.18632/oncotarget.7108 ID - Fontana2016 ER - TY - JOUR AU - Huang, L. AU - Balavarca, Y. AU - Geest, L. AU - Lemmens, V. AU - Eycken, L. AU - Schutter, H. PY - 2019 DA - 2019// TI - Development and validation of a prognostic model to predict the prognosis of patients who underwent chemotherapy and resection of pancreatic adenocarcinoma: a large international population-based cohort study JO - BMC Med VL - 17 UR - https://doi.org/10.1186/s12916-019-1304-y DO - 10.1186/s12916-019-1304-y ID - Huang2019 ER - TY - JOUR AU - Shi, X. H. AU - Li, X. AU - Zhang, H. AU - He, R. Z. AU - Zhao, Y. AU - Zhou, M. PY - 2018 DA - 2018// TI - A five-microRNA signature for survival prognosis in pancreatic adenocarcinoma based on TCGA data JO - Sci Rep VL - 8 UR - https://doi.org/10.1038/s41598-018-22493-5 DO - 10.1038/s41598-018-22493-5 ID - Shi2018 ER - TY - JOUR AU - Pages, F. AU - Mlecnik, B. AU - Marliot, F. AU - Bindea, G. AU - Ou, F. S. AU - Bifulco, C. PY - 2018 DA - 2018// TI - International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study JO - Lancet. VL - 391 UR - https://doi.org/10.1016/S0140-6736(18)30789-X DO - 10.1016/S0140-6736(18)30789-X ID - Pages2018 ER - TY - JOUR AU - Cui, C. AU - Tian, X. AU - Wu, J. AU - Zhang, C. AU - Tan, Q. AU - Guan, X. PY - 2018 DA - 2018// TI - T cell receptor beta-chain repertoire analysis of tumor infiltrating lymphocytes in pancreatic cancer JO - Cancer Sci VL - 110 UR - https://doi.org/10.1111/cas.13877 DO - 10.1111/cas.13877 ID - Cui2018 ER - TY - JOUR AU - Ene-Obong, A. AU - Clear, A. J. AU - Watt, J. AU - Wang, J. AU - Fatah, R. AU - Riches, J. C. PY - 2013 DA - 2013// TI - Activated pancreatic stellate cells sequester CD8+ T cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinoma JO - Gastroenterology VL - 145 UR - https://doi.org/10.1053/j.gastro.2013.07.025 DO - 10.1053/j.gastro.2013.07.025 ID - Ene-Obong2013 ER - TY - JOUR AU - Carstens, J. L. AU - Correa de Sampaio, P. AU - Yang, D. AU - Barua, S. AU - Wang, H. AU - Rao, A. PY - 2017 DA - 2017// TI - Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer JO - Nat Commun VL - 8 UR - https://doi.org/10.1038/ncomms15095 DO - 10.1038/ncomms15095 ID - Carstens2017 ER - TY - JOUR AU - Wu, S. P. AU - Liao, R. Q. AU - Tu, H. Y. AU - Wang, W. J. AU - Dong, Z. Y. AU - Huang, S. M. PY - 2018 DA - 2018// TI - Stromal PD-L1-positive regulatory T cells and PD-1-positive CD8-positive T cells define the response of different subsets of non-small cell lung Cancer to PD-1/PD-L1 blockade immunotherapy JO - J Thorac Oncol VL - 13 UR - https://doi.org/10.1016/j.jtho.2017.11.132 DO - 10.1016/j.jtho.2017.11.132 ID - Wu2018 ER - TY - JOUR AU - Harada, K. AU - Dong, X. AU - Estrella, J. S. AU - Correa, A. M. AU - Xu, Y. AU - Hofstetter, W. L. PY - 2018 DA - 2018// TI - Tumor-associated macrophage infiltration is highly associated with PD-L1 expression in gastric adenocarcinoma JO - Gastric Cancer VL - 21 UR - https://doi.org/10.1007/s10120-017-0760-3 DO - 10.1007/s10120-017-0760-3 ID - Harada2018 ER - TY - JOUR AU - Pinton, L. AU - Solito, S. AU - Damuzzo, V. AU - Francescato, S. AU - Pozzuoli, A. AU - Berizzi, A. PY - 2016 DA - 2016// TI - Activated T cells sustain myeloid-derived suppressor cell-mediated immune suppression JO - Oncotarget VL - 7 UR - https://doi.org/10.18632/oncotarget.6662 DO - 10.18632/oncotarget.6662 ID - Pinton2016 ER - TY - JOUR AU - Diaz-Montero, C. M. AU - Salem, M. L. AU - Nishimura, M. I. AU - Garrett-Mayer, E. AU - Cole, D. J. AU - Montero, A. J. PY - 2009 DA - 2009// TI - Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy JO - Cancer Immunol Immunother VL - 58 UR - https://doi.org/10.1007/s00262-008-0523-4 DO - 10.1007/s00262-008-0523-4 ID - Diaz-Montero2009 ER - TY - JOUR AU - Chen, Y. P. AU - Wang, Y. Q. AU - Lv, J. W. AU - Li, Y. Q. AU - Chua, M. L. K. AU - Le, Q. T. PY - 2019 DA - 2019// TI - Identification and validation of novel microenvironment-based immune molecular subgroups of head and neck squamous cell carcinoma: implications for immunotherapy JO - Ann Oncol VL - 30 UR - https://doi.org/10.1093/annonc/mdy470 DO - 10.1093/annonc/mdy470 ID - Chen2019 ER - TY - JOUR AU - Giaccone, G. AU - Bazhenova, L. A. AU - Nemunaitis, J. AU - Tan, M. AU - Juhasz, E. AU - Ramlau, R. PY - 2015 DA - 2015// TI - A phase III study of belagenpumatucel-L, an allogeneic tumour cell vaccine, as maintenance therapy for non-small cell lung cancer JO - Eur J Cancer VL - 51 UR - https://doi.org/10.1016/j.ejca.2015.07.035 DO - 10.1016/j.ejca.2015.07.035 ID - Giaccone2015 ER - TY - JOUR AU - Trieu, V. N. AU - D'Cruz, O. AU - Qazi, S. AU - Ng, K. AU - Hwang, L. PY - 2017 DA - 2017// TI - Correlation of circulating IL-8 levels with improved overall survival in advanced pancreatic cancer patients in response to antisense OT-101 (trabedersen) therapy JO - J Clin Oncol VL - 35 UR - https://doi.org/10.1200/JCO.2017.35.4_suppl.444 DO - 10.1200/JCO.2017.35.4_suppl.444 ID - Trieu2017 ER - TY - JOUR AU - Schildberg, F. A. AU - Klein, S. R. AU - Freeman, G. J. AU - Sharpe, A. H. PY - 2016 DA - 2016// TI - Coinhibitory pathways in the B7-CD28 ligand-receptor family JO - Immunity VL - 44 UR - https://doi.org/10.1016/j.immuni.2016.05.002 DO - 10.1016/j.immuni.2016.05.002 ID - Schildberg2016 ER - TY - JOUR AU - Xiang, H. AU - Zhao, W. AU - Sun, Y. AU - Qian, W. AU - Xing, J. AU - Zhou, Y. PY - 2012 DA - 2012// TI - CD86 gene variants and susceptibility to pancreatic cancer JO - J Cancer Res Clin Oncol VL - 138 UR - https://doi.org/10.1007/s00432-012-1289-9 DO - 10.1007/s00432-012-1289-9 ID - Xiang2012 ER - TY - JOUR AU - Sideras, K. AU - Biermann, K. AU - Yap, K. AU - Mancham, S. AU - Boor, P. P. C. AU - Hansen, B. E. PY - 2017 DA - 2017// TI - Tumor cell expression of immune inhibitory molecules and tumor-infiltrating lymphocyte count predict cancer-specific survival in pancreatic and ampullary cancer JO - Int J Cancer VL - 141 UR - https://doi.org/10.1002/ijc.30760 DO - 10.1002/ijc.30760 ID - Sideras2017 ER - TY - JOUR AU - Gorchs, L. AU - Fernandez Moro, C. AU - Bankhead, P. AU - Kern, K. P. AU - Sadeak, I. AU - Meng, Q. PY - 2019 DA - 2019// TI - Human pancreatic carcinoma-associated fibroblasts promote expression of co-inhibitory markers on CD4(+) and CD8(+) T-cells JO - Front Immunol VL - 10 UR - https://doi.org/10.3389/fimmu.2019.00847 DO - 10.3389/fimmu.2019.00847 ID - Gorchs2019 ER - TY - JOUR AU - Costantini, A. AU - Julie, C. AU - Dumenil, C. AU - Helias-Rodzewicz, Z. AU - Tisserand, J. AU - Dumoulin, J. PY - 2018 DA - 2018// TI - Predictive role of plasmatic biomarkers in advanced non-small cell lung cancer treated by nivolumab JO - Oncoimmunology VL - 7 UR - https://doi.org/10.1080/2162402X.2018.1452581 DO - 10.1080/2162402X.2018.1452581 ID - Costantini2018 ER - TY - JOUR AU - Ahmad, S. M. AU - Martinenaite, E. AU - Holmstrom, M. AU - Jorgensen, M. A. AU - Met, O. AU - Nastasi, C. PY - 2018 DA - 2018// TI - The inhibitory checkpoint, PD-L2, is a target for effector T cells: novel possibilities for immune therapy JO - Oncoimmunology VL - 7 UR - https://doi.org/10.1080/2162402X.2017.1390641 DO - 10.1080/2162402X.2017.1390641 ID - Ahmad2018 ER -